Analysts expect Anaptysbio, Inc to report revenue of 42.82 M for Q1 27, against a range of 40.56 M to 45.09 M. The most recent reported quarter, Q4 26, came in at 27.49 M, a 3.5% beat against the 26.56 M consensus.
| Metric | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 7.18 M | 10.97 M | 30.02 M | 43.11 M | 27.77 M | 22.26 M | 25.56 M | 27.49 M | - | - | - | - | - | - | - | - | ||||||||
| High Estimate | 4.34 M | 22.06 M | 8.92 M | 8.86 M | 30.68 M | 22.04 M | 25.35 M | 27.99 M | 45.09 M | 59.17 M | 50.55 M | 58.00 M | 59.76 M | 73.61 M | 85.57 M | 96.67 M | ||||||||
| Low Estimate | 3.93 M | 20.30 M | 8.36 M | 7.65 M | 26.06 M | 20.13 M | 23.51 M | 25.13 M | 40.56 M | 55.63 M | 46.10 M | 53.02 M | 54.98 M | 67.48 M | 73.79 M | 85.48 M | ||||||||
| Consensus Estimate | 4.14 M | 21.18 M | 8.64 M | 8.26 M | 28.37 M | 21.08 M | 24.43 M | 26.56 M | 42.82 M | 57.40 M | 48.32 M | 55.51 M | 57.37 M | 70.55 M | 79.68 M | 91.08 M |
Analysts expect Anaptysbio, Inc to report earnings per share of 0.88 for Q1 27, against a range of 0.80 to 0.96. The most recent reported quarter, Q4 26, came in at 5.11, a 7.4% beat against the 4.76 consensus.
| Metric | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -1.09 | -1.14 | -0.76 | -0.48 | -0.85 | -0.89 | -1.84 | 5.11 | - | - | - | - | - | - | - | - | ||||||||
| High Estimate | -0.92 | -0.68 | -1.05 | -1.02 | -0.81 | -0.77 | -1.58 | 5.13 | 0.96 | 2.01 | 1.37 | 1.55 | 0.22 | 2.00 | 2.70 | 2.59 | ||||||||
| Low Estimate | -1.08 | -0.78 | -1.25 | -1.22 | -0.99 | -0.91 | -1.88 | 4.39 | 0.80 | 1.65 | 1.19 | 1.35 | 0.20 | 1.86 | 2.28 | 2.39 | ||||||||
| Consensus Estimate | -1.00 | -0.73 | -1.15 | -1.12 | -0.90 | -0.84 | -1.73 | 4.76 | 0.88 | 1.83 | 1.28 | 1.45 | 0.21 | 1.93 | 2.49 | 2.49 |
Pull Wall Street consensus for Anaptysbio, Inc (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=ANAB&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "ANAB", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=ANAB&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();